Sancilio and Company, Inc. (SCI) is a biopharmaceutical company focused on Advanced Lipid Technology (ALT) and complimentary products. Unlike most research stage companies, SCI has developed a portfolio of commercialized products that are developed, manufactured and distributed by our own dedicated people in our own cGMP manufacturing facilities. We are building all the necessary systems, facilities and expertise to allow us to maximize the value of our robust research pipeline that includes highly concentrated essential fatty acids, improvements to bioavailablility of these and other products.
Headquartered in Palm Beach County, Florida, SCI occupies over 40,000 square feet of modern offices, laboratories, and production facilities. With two New Drug Applications entering a critical clinical phase, and two additional ANDAs being prepared for submission to the US FDA this year, the company is poised to become a dominant contender in the specialty pharmaceutical market.
Also visit: www.oceanblueprofessional.com